Developing countries such as South Korea, Brazil, India, and Mexico are likely to provide substantial growth possibilities for urinalysis industry players. This is due to a rise in the prevalence of chronic diseases, improved healthcare infrastructure, a bigger patient population, and more disposable income. In India, for example, healthcare spending went from USD 232.73 million in 2020 to USD 507.97 million in 2021. Furthermore, governments conduct screening programs to detect ailments such as urinary and renal abnormalities early. For example, under school urinary analysis programs, approximately 12,497 kids from primary and secondary schools in Pingyang, Cangnan, and Yongjia in Wenzhou, China were checked for urinalysis.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/global-urinalysis-market
Data Bridge Market Research analyses that the Urinalysis Market is expected to grow at a CAGR of 6% during the forecast period of 2022 to 2029, at a USD 3.18 billion in 2021 and is further estimated to reach USD 5.07 billion by 2029. One of the primary factors propelling the market forward is the rising prevalence of urinary tract infections (UTIs) in emerging countries. If left untreated, urinary tract infections (UTIs) can spread to the kidneys and cause delivery difficulties in pregnant women, which is a major reason driving market growth.
Growing diabetic population base is expected to drive the market's growth rate
According to the National Diabetes Statistics Report, 2020, around 34.2 million people aged 18 and up in the United States had diabetes. One-third of diabetics develop kidney-related comorbidities as a result of elevated blood sugar and blood pressure. Urinalysis is a noninvasive and informative diagnostic procedure that clinicians can use to diagnose kidney disease. As a result, the increased frequency of renal illnesses is expected to raise demand for urinalysis products, driving market expansion.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014- 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Testing Type (Urine Biochemistry Testing and Urine Sediment Testing), Product (Instruments and Consumables), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility and Others), End User (Hospital, Laboratory, Home Care Setting and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), Siemens (Germany), BD (U.S.), Thermo Fisher Scientific (U.S.), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Beckman Coulter Inc. (U.S.), ACON Laboratories Inc. (U.S.), ARKRAY Inc. (Japan), Trinity Biotech (Ireland), Quidel Corporation (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan), Analyticon Biotechnologies Ag (Germany), Ekf Diagnostics (U.K.), Hti Medical Inc. (U.S.), Teco Diagnostics (U.S.), Tenko Medical System Corp (U.S.), Wama Diagnostica (Brazil)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global urinalysis market is segmented into six notable segments which are based on the testing type, product, modality, application, end user and distribution channel.
- On the basis of testing type, global urinalysis market is segmented into urine biochemistry testing and urine sediment testing.
In 2022, the urine biochemistry testing segment is expected to dominate the urinalysis market
The urine biochemistry testing segment is expected to dominate the urinalysis market with 50.46% market share due to the growing advancement in the testing operations with the help of technology.
- On the basis of product, global urinalysis market is segmented into instruments and consumables. In 2022, the instruments segment is expected to dominate the urinalysis market due to the need for performing automatic accurate urine testing.
- On the basis of modality, global urinalysis market is segmented into portable, standlon, table top, bench top and others. In 2022, the portable segment is expected to dominate the urinalysis market due to the prevalence of urinary tract infections and the need to get the maximum relevant information with the help of modalities.
- On the basis of application, global urinalysis market is segmented into urinary tract infections, kidney diseases, diabetes, liver diseases, pregnancy & fertility and others.
In 2022, the urinary tract infections segment is expected to dominate the urinalysis market
The urinary tract infections segment is expected to dominate the urinalysis market due to growing prevalence of urinary infections as it is considered as the most common outpatient infections with a life time incidence of more than 60% in adult women.
- On the basis of end-user, global urinalysis market is segmented into hospital, laboratory, homecare setting and others. In 2022, the hospital segment is expected to dominate the urinalysis market with 50.46% market share due to presence of trained professionals.
- On the basis of distribution channel segment, global urinalysis market is segmented into direct tenders and retail sales. In 2022, the direct tenders segment is expected to dominate the urinalysis market due to increased demand of advanced technologies and testing requirements in medical care for urinalysis operations and diagnosis.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Abbott (U.S.), Siemens (Germany), BD (U.S.), Thermo Fisher Scientific (U.S.), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Beckman Coulter Inc. (U.S.), ACON Laboratories Inc. (U.S.), ARKRAY Inc. (Japan), Trinity Biotech (Ireland), Quidel Corporation (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan), Analyticon Biotechnologies Ag (Germany), Ekf Diagnostics (U.K.), Hti Medical Inc. (U.S.), Teco Diagnostics (U.S.), Tenko Medical System Corp (U.S.), Wama Diagnostica (Brazil).
Market Development
- In 2022, Bio-Rad Laboratories, Inc. launched the qUAntify Advanced Control equipment in January to monitor the precision urinalysis test procedure in clinical labs. This equipment improved the laboratory's statistical process control and product demand in the approaching years.
- In 2020, The TestCard non-invasive at-home UTI test kit was launched in the UK in August. The companion smartphone app allows consumers to view testing results and communicate information with a healthcare practitioner. This test kit can be purchased at a retail drugstore for USD 12.06.
- In 2021, KDx Diagnostics, Inc. and Lister Hospital launched KDx's URO17 non-invasive urine test for the diagnosis of bladder cancer in the United Kingdom in December. This launch was intended to boost its market position.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the urinalysis market during the forecast period 2022 to 2029
Given the increased use of urinalysis for the treatment of liver disease and urinary tract infections, North America dominates the urinalysis industry. Furthermore, the growing number of Urinalysis patients will drive the region's urinalysis market growth during the projection period.
Asia-Pacific is estimated to be the fastest growing region in the urinalysis market in the forecast period 2022 to 2029
Given of the increased government activities to raise awareness about the importance of diagnosis and rising healthcare expenditures in the region, Asia-Pacific is expected to see considerable growth in the urinalysis market.
For more detailed information about the urinalysis market report, click here – https://www.databridgemarketresearch.com/es/reports/global-urinalysis-market
